Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Tariffs on pharmaceutical imports could hurt Lilly, especially with its dependence on products made in Ireland. The president ...

Eli Lilly's (NYSE: LLY) share price soared during the first Trump administration ... He didn't provide details, though, on how much of an impact tariffs might have on Lilly.

Let's consider two corporations that could help you do better than average in the next decade: Eli Lilly (NYSE: LLY) and ...

On Tuesday, Bernstein analysts maintained a positive outlook on Eli Lilly (NYSE: LLY) shares, reiterating their Outperform rating and a price target of $1,100.00.

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.